Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Louis Edward Tamayo

CFO at Lexeo Therapeutics, Inc. (LXEO)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $41K

Reported trades

Filed Stock Type Shares Price Value Since
Aug 19SEC LXEOLexeo Therapeutics, Inc. Sell 4,11792,907 held (−4%) $4.91 $20K -46.2%
Jul 1SEC LXEOLexeo Therapeutics, Inc. Sell 4,64197,024 held (−5%) $4.49 $21K -41.2%